|
May 5
|
Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
|
|
May 3
|
Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
|
|
May 2
|
Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says
|
|
May 2
|
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
|
|
May 2
|
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Q1 2024 Sarepta Therapeutics Inc Earnings Call
|
|
May 2
|
Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
|
|
May 1
|
Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 1
|
Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
|
|
May 1
|
Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates
|
|
May 1
|
Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
|
|
May 1
|
1 Top Growth Stock to Buy and Hold for 10 Years
|
|
Apr 30
|
Why Sarepta (SRPT) Might Surprise This Earnings Season
|
|
Apr 29
|
Sarepta Therapeutics Stock Shows Improved Technical Strength
|
|
Apr 26
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Apr 25
|
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 25
|
Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock
|
|
Apr 24
|
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
|
|
Apr 14
|
10 Unstoppable Stocks That Will Make You Richer
|
|
Apr 8
|
Why Sarepta's First-Quarter Report Is Already Dead In The Water: Analyst
|